Valeant has gained FDA approval for psoriasis drug Siliq – but side effect warnings about suicidal ideation look set to limit sales. Originally developed by Amgen and AstraZeneca, a suicidal ...

Valeant Pharmaceuticals North America LLC., Sanofi Biosurgery Inc., Anika Therapeutics, Inc., and Suneva Medical, Inc. These industry leaders are actively involved in partnerships and product ...

IBS has classically been regarded as a “diagnosis of exclusion,” but new research suggested that might be changing with better diagnostic and treatment approaches.

Teva and Valeant. "Both the quality and quantity of disclosure regarding environmental impacts and climate change risk were considered" Both the quality and quantity of disclosure regarding ...

Super Micro Computer's Q1 results are overshadowed by auditor issues and DOJ investigations. See why SMCI stock remains risky ...

The for-profit education company focused on health care professionals is bucking the trend of downtown office tenants ...

The global body contouring treatments market growth forecasted to transform from USD 1.46 billion in 2024 to USD 2.58 billion ...

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its cardiovascular portfolio at the American Heart Association (AHA) Annual Scientific Sessions, taking place this week ...

Bausch Health Companies Inc (BHC) reports robust revenue growth and strategic initiatives, while navigating ongoing legal and market challenges.

Between 2019 and 2023, the market grew at a CAGR of 9%, driven by the rising health-consciousness of consumers, particularly millennial and Gen-Z parents. As precision nutrition technologies advance, ...

BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.

The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...